INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2015. The put-call ratio across all filers is 2.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $5,614,304,000 | -47.3% | 144,624 | -62.2% | 1.22% | -42.1% |
| Q1 2016 | $10,645,287,000 | -43.9% | 382,924 | +8.5% | 2.11% | +0.1% |
| Q4 2015 | $18,983,782,000 | -14.8% | 352,924 | -36.6% | 2.11% | -34.8% |
| Q3 2015 | $22,271,209,000 | +432015.0% | 556,224 | +244.8% | 3.24% | +266.1% |
| Q2 2015 | $5,154,000 | +43.8% | 161,300 | +7.5% | 0.88% | +1.4% |
| Q1 2015 | $3,584,000 | – | 150,100 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCF Advisers, LLC | 359,000 | $18,790,000 | 7.62% |
| Velan Capital Investment Management LP | 150,000 | $7,851,000 | 6.09% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 195,000 | $10,206,000 | 4.14% |
| Vantage Consulting Group Inc | 226,670 | $11,864,000 | 3.19% |
| Vahanian & Associates Financial Planning Inc. | 71,742 | $3,755,000 | 3.03% |
| Nicholas Investment Partners, LP | 652,886 | $34,172,000 | 2.16% |
| COOPER/HAIMS ADVISORS, LLC | 61,116 | $3,199,000 | 1.97% |
| Bellevue Group AG | 3,628,919 | $189,938,000 | 1.96% |
| WASATCH ADVISORS LP | 8,235,171 | $431,029,000 | 1.76% |
| Quantum Private Wealth, LLC | 77,622 | $4,062,000 | 1.54% |